Emergent BioSolutions (EBS) EV to CFO (2010 - 2026)
Emergent BioSolutions (EBS) posted EV to CFO of 5.15 for Q2 2026, up 164.86% on a QoQ basis from 7.94 in Q1 2026, and up 665.45% year-over-year from 0.67 in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) EV to CFO (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported EV to CFO for 17 years, with the latest figure at 5.15 in Q2 2026.
- On a quarterly basis, EV to CFO rose 665.45% year-over-year to 5.15 in Q2 2026; TTM through Jun 2026 was 2.96, a 598.12% increase from a year earlier, with the FY2025 full-year figure at 2.55, down 63.82% from the prior year.
- EV to CFO was 5.15 for Q2 2026 at Emergent BioSolutions, up from 7.94 in the prior quarter.
- The five-year high for EV to CFO was 6.1 in Q2 2024, with the low at 93.75 in Q3 2025.
- Average EV to CFO over 5 years is 12.83, with a median of 0.7 recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: EV to CFO slumped 4978.74% in 2025, then jumped 665.45% in 2026.
- Over 5 years, EV to CFO stood at 0.55 in 2022, then soared by 177.1% to 0.42 in 2023, then plunged by 1323.33% to 5.18 in 2024, then soared by 208.14% to 5.6 in 2025, then retreated by 7.95% to 5.15 in 2026.
- The last three EV to CFO figures came in at 5.15 (Q2 2026), 7.94 (Q1 2026), and 5.6 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 |
| Mar 31, 2026 | -7.94 |
| Dec 31, 2025 | 5.60 |
| Sep 30, 2025 | -93.75 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | -10.01 |
| Dec 31, 2024 | -5.18 |
| Sep 30, 2024 | 1.92 |
| Jun 30, 2024 | 6.10 |
| Mar 31, 2024 | -0.86 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 1.47 |
| Jun 30, 2023 | -2.55 |
| Mar 31, 2023 | -0.50 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -10.90 |
| Jun 30, 2022 | -76.32 |
| Mar 31, 2022 | -43.79 |
| Dec 31, 2021 | 5.04 |
| Sep 30, 2021 | 136.81 |
API Access
Emergent BioSolutions EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();